Insider Purchases: Inside the Buy
Tag: stock market
🌿 SiteOne Landscape Supply (SITE): CEO Buys $816K as This $36B Market Leader Nears 52-Week Lows
SiteOne Landscape Supply isn't flashy—but it may be one of the market's most overlooked industrial compounders. After a sharp correction, CEO Doug Black invested more than $816,000 of his own money while institutions continue to dominate the shareholder base. We examine the valuation, competitive moat, earnings, risks, and whether this roll-up story deserves another look.
🧬 Ionis Pharmaceuticals (IONS): The RNA Arbitrage — $2.1B Cash, $1M Insider Buy, and the Post-Trial Collapse
Ionis Pharmaceuticals (NASDAQ: IONS) lost billions in market value after a disappointing clinical trial—but one director immediately bought more than $1 million worth of shares. Is Wall Street missing the bigger RNA platform story? Here's the full analysis.
🥑 Mission Produce (AVO) Stock Analysis: Why Insiders Just Bought $7.9 Million of Stock
Mission Produce's directors recently deployed nearly $7.9 million of personal capital into AVO shares. Combined with the Calavo acquisition, a fresh $100 million buyback, and a move into higher-margin prepared foods, the avocado giant may be entering a new chapter.
💳 Fiserv Insiders Keep Averaging Down. Wall Street Sees Trouble. Bulls See A 6x Earnings Cash Machine.
Fiserv's executives are putting their money where their mouths are. With insider buying surging, Clover processing $324 billion annually, and valuation multiples near historic lows, the payments giant has become one of Wall Street's more fascinating turnarounds.
🏗️ AECOM (ACM): The $26 Billion Backlog Infrastructure Giant Trading at 12x Earnings
AECOM (NYSE: ACM) may be one of the most misunderstood infrastructure stocks in the market. With a record $26.2 billion backlog, insider buying from top executives, and a surprisingly cheap valuation, this engineering and consulting powerhouse could be quietly laying the foundation for substantial long-term upside.
🥚 Vital Farms (VITL): The Great Egg Glut of 2026
Vital Farms stock has been absolutely scrambled by the 2026 egg glut, plunging more than 80% from its highs as profitability collapsed and short sellers flooded the farm. But coordinated insider buying, a debt-free balance sheet, and extreme institutional ownership suggest the setup may be far more explosive than the market currently realizes.
🐟 Nomad Foods (NOMD): The Frozen Food Giant Trading Like a Distressed Stock
Nomad Foods may not be sexy, but Europe’s frozen-food empire is suddenly attracting serious insider buying, quant fund interest, and deep-value investors. With a near-7% dividend yield, aggressive buybacks, and a forward P/E near 5x, NOMD might be one of the market’s coldest contrarian opportunities.
Lululemon (LULU): 68% Off — Bargain or Value Trap? 🧘
Lululemon (LULU) has fallen sharply from its highs, but insider buying and international growth suggest opportunity. Is this a contrarian buy—or a value trap in disguise?
Is Boeing Ready to Fly?
Boeing’s new director — ex-Vanguard CEO Tim Buckley — just bought nearly $500K of stock. With a $619B backlog and cash flow stabilizing, is this aerospace giant finally ready for liftoff… or more turbulence?
iHeartMedia (IHRT): Turning the Volume Back Up?
Insiders are piling in, institutions are holding strong, and iHeartMedia is betting big on podcasts to fuel its turnaround. But with heavy debt and radio stagnation, is IHRT a hidden gem or just background noise?